Investigating Immunotherapy & Its Role in NSCLC

Investigating Immunotherapy & Its Role in NSCLC

ReachMD Healthcare Image

When is it best to use immunotherapy for patients with lung cancer, and how can we best monitor it?

  • Overview

    Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung cancer with Dr. Mark Awad, a thoracic medical oncologist, Clinical Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School.­

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free